Researchers uncover corneal changes in multiple myeloma patients treated with belantamab mafodotin, revealing potential ...

Q1 2025 Earnings Call Transcript May 9, 2025 Kymera Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.82, expectations were $-0.92. Justine Koenigsberg: Good morning, and welcome to ...

Tim Friede has injected himself with snake venom hundreds of times, and subjected himself to more than 200 bites. Now, ...

You’ve worked extensively on respiratory syncytial virus (RSV) and influenza. What are the key differences in how the immune ...